Skip to main content

Diabetes

  • Aristides Spanellis prohibited from buying, selling LifeScan's blood-glucose monitoring test strips

    MILPITAS, Calif. — LifeScan announced a major settlement regarding counterfeit packaged LifeScan blood-glucose monitoring test strips sold by Aristides Spanellis.

  • GDM risk can be assessed prior to pregnancy

    OAKLAND, Calif. — A woman's risk of developing a type of diabetes typically caused by pregnancy can be identified up to seven years prior to becoming pregnant, according to a new study by Kaiser Permanente.

    The study, part of Kaiser Permanente's ongoing research to understand, prevent and treat gestational diabetes mellitus, found that routinely assessing blood sugar and body weight measures can provide women with insight on their risk of developing GDM.

  • Sanofi: Lyxumia won't significantly increase hypoglycemia risk

    PARIS — New results from a late-stage clinical trial of a Sanofi drug for Type 2 diabetes indicated that the drug can reduce blood sugar in patients without increasing the risk of causing the blood sugar levels to dip too low, the French drug maker said Tuesday.

  • Court grants Amylin temporary restraining order to bar Lilly from using same sales team

    SAN DIEGO — Eli Lilly is temporarily barred from using the same sales team to market two diabetes drugs, under a court order issued Thursday.

  • Study: CT scans could help predict early death among diabetes patients

    WAKE FOREST, N.C. — A common test may help predict early death among diabetes patients, a new study found.

    According to research lead by Donald Bowden, director of the Center for Diabetes Research at Wake Forest Baptist Medical Center, the examination of a patient's coronary artery calcium score — which measures the amount of calcified plaque buildup in blood vessels — through a computed tomography scan, or CT scan, could indicate the patient's risk of coronary heart disease, which can lead to premature death.

  • Many caregivers forgo their own medication adherence, research finds

    WOONSOCKET, R.I. — Many people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark. Given this, there's a significant opportunity for pharmacists and doctors to identify and work with caregivers to improve medication adherence and chronic disease management.

  • Walgreens, Johns Hopkins Medicine announce chronic disease research collaboration

    CHICAGO — Johns Hopkins Medicine and Walgreens on Wednesday announced an agreement between the two companies that will promote collaboration on population-based research.

    Also part of the agreement, Johns Hopkins and Walgreens will jointly review and develop protocols to improve outcomes of patients with chronic diseases and explore the development of new models for improving care for individuals.

  • Study: Diabetics at higher risk of tuberculosis infection

    NEW YORK — Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

    The study investigators discovered among 233 patients that were diagnosed with TB between March 2006 and March 2008 — which included 61 patients in southern Texas and 172 in northeastern Mexico — 25% of TB cases were attributed to the presence of diabetes, while 6% of TB cases were caused by HIV.

X
This ad will auto-close in 10 seconds